Chargement en cours...
Use of SGLT-2 Inhibitors in Patients With Type 1 Diabetes Mellitus
Introduction: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are the newest class of oral antihyperglycemic medications approved for the treatment of type 2 diabetes mellitus (DM2). Although they are not approved for use in type 1 diabetes mellitus (DM1), SGLT2 inhibitors may help DM1 patients a...
Enregistré dans:
| Publié dans: | J Prim Care Community Health |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6940598/ https://ncbi.nlm.nih.gov/pubmed/31894715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2150132719895188 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|